Ventricular septal defects (VSDs) are the most common congenital heart defects, accounting for 30-40% of congenital cardiac anomalies. They result from an abnormal opening in the interventricular septum, leading to left-to-right shunting. Clinical presentation depends on defect size and pulmonary vascular resistance, ranging from asymptomatic small defects to heart failure symptoms in infancy, with older children developing exercise intolerance or pulmonary hypertension.
Although surgical closure has long been the standard treatment, percutaneous transcatheter device closure has emerged as a less invasive alternative for selected VSD types, particularly muscular and suitable perimembranous defects. This approach offers comparable efficacy with reduced morbidity and shorter hospital stays.
This bicentric study aims to evaluate procedural success, complications, and short-term outcomes of percutaneous VSD closure in paediatric patients from Upper Egypt, providing essential data to guide clinical practice and quality improvement in tertiary cardiac centres.
Inclusion Criteria:
Age: 6 months to 18 years
Confirmed diagnosis of VSD (perimembranous, muscular) by transthoracic echocardiography (TTE)
Hemodynamically significant VSD with: (Imtiaz et al., 2023)
Suitable anatomy for device closure as assessed by TTE and/or transesophageal echocardiography (TEE)
Adequate rim (≥2mm) from VSD edges to cardiac valves and conduction system (for perimembranous VSDs)
Written informed consent from parents/legal guardians
Assent from children ≥ 12 years (as appropriate
Exclusion Criteria:
An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
Transcatheter Versus Surgical Closure of Ventricular Septal Defect: A Comparative Study
Procedural Outcomes of Percutaneous PDA Closure: Comparative Study Between Different Devices.
A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects
Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
Assessment of LV/RV S and SR Before and After Percutaneous Closure of ASDs
Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects